Relatório global de análise do tamanho, quota e tendências do mercado de catarata – Visão geral do setor e previsão para 2031

Análise do mercado de catarata

A catarata, caracterizada pela turvação do cristalino natural do olho, continua a ser uma das principais causas de deficiência visual em todo o mundo. Esta condição geralmente progride com a idade, mas também pode resultar de trauma, de certos medicamentos ou de fatores genéticos. Os desenvolvimentos recentes no tratamento da catarata centram-se em lentes intraoculares (LIOs) avançadas e técnicas cirúrgicas melhoradas. Por exemplo, o lançamento da LIO AcrySof IQ Vivity pela Alcon em janeiro de 2022 representa um avanço significativo, utilizando tecnologia de modelação de frente de onda para melhorar a clareza visual e corrigir a presbiopia. Da mesma forma, a integração da tecnologia laser de femtosegundos na cirurgia de catarata melhorou a precisão e a segurança, reduzindo os tempos de recuperação e melhorando os resultados. Além disso, a investigação em curso está a explorar novos tratamentos farmacológicos para prevenir ou retardar a formação de cataratas, oferecendo potencialmente alternativas não cirúrgicas no futuro. Estas inovações sublinham a evolução dinâmica do tratamento da catarata, com o objetivo de melhorar os resultados visuais e a qualidade de vida dos doentes em todo o mundo.

Tamanho do mercado de catarata

O tamanho do mercado global de Cataratas foi avaliado em 5,28 mil milhões de dólares em 2023 e deverá atingir 8,41 mil milhões de dólares até 2031, com um CAGR de 6,0% durante o período de previsão de 2024 a 2031. Para além dos insights sobre cenários de mercado, tais como mercado valor, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análises especializadas aprofundadas, epidemiologia de pacientes, análise de pipeline, análise de preços e estrutura regulatória.

Tendências do mercado de catarata

“Aumento das Lentes Intraoculares (LIOs) Premium”

O mercado da catarata está a registar um crescimento significativo, impulsionado pela crescente prevalência da catarata relacionada com a idade e pelos avanços nas tecnologias cirúrgicas. Uma tendência proeminente é o aumento de lentes intraoculares (LIOs) premium, que oferecem resultados visuais melhorados em comparação com as opções tradicionais. Por exemplo, a LIO TECNIS Symfony da Johnson & Johnson MedTech representa um avanço no tratamento da catarata, proporcionando uma maior profundidade de foco e uma melhor visão noturna, abordando limitações comuns das LIO standard. Esta tendência reflete uma mudança mais ampla para tratamentos de catarata personalizados e avançados que atendem às diversas necessidades dos doentes. A integração de tecnologia de ponta, como sistemas de imagem avançados e técnicas cirúrgicas minimamente invasivas, aumenta ainda mais a precisão e a eficácia da cirurgia de catarata. Esta tendência não só melhora a satisfação dos doentes, como também impulsiona o crescimento do mercado à medida que os prestadores de cuidados de saúde adotam estas soluções inovadoras para satisfazer as crescentes exigências do tratamento da catarata.

Âmbito do relatório e segmentação do mercado de catarata   

Cataracts Market Definition

Cataracts are a common eye condition characterized by the clouding of the eye's natural lens, which leads to a decrease in vision clarity. The lens, normally transparent, becomes opaque or cloudy, obstructing light from passing through to the retina. This clouding can cause blurred vision, difficulty seeing at night, sensitivity to glare, and color distortion. Cataracts often develop gradually and are typically associated with aging, though they can also result from other factors such as trauma, certain medications, or genetic conditions. Treatment usually involves surgical removal of the cloudy lens and replacement with an artificial intraocular lens (IOL).

Cataracts Market Dynamics

Drivers

• Rising Geriatric Population

The global aging population is a major driver of the cataracts market, given that cataracts predominantly affect older adults. According to the World Health Organization (WHO), the number of people aged 60 and over is projected to reach 2.1 billion by 2050, up from 1.2 billion in 2019. This significant increase in the elderly population correlates with a higher incidence of cataracts, with about 10 million cataract surgeries performed globally each year. The rising number of elderly individuals is expected to further drive demand for cataract treatments, as age is the primary risk factor for this condition. As the population ages, the need for effective cataract management solutions, including advanced surgical techniques and innovative treatment options, will continue to grow, influencing the market's expansion.

• Rising Prevalence of Risk Factors

The rising prevalence of risk factors such as diabetes and obesity significantly drives the demand for cataract management solutions. Diabetes, which affects over 537 million adults globally as reported by the International Diabetes Federation (IDF) in 2021, is a major contributor to cataract formation due to its impact on blood sugar levels and subsequent damage to eye tissues. Additionally, obesity, a condition that has reached epidemic proportions with over 2.8 million deaths annually linked to obesity-related diseases, is associated with an increased risk of developing cataracts. As these risk factors become more prevalent, the need for cataract treatments and management solutions grows, driving the market for advanced surgical and pharmaceutical interventions.

Opportunities

• Innovative Treatment Modalities

Innovative treatment modalities are significantly expanding the cataracts market with advanced drug delivery systems and pharmacological therapies. Research into nanotechnology-based drug delivery is developing non-surgical options by targeting cataract-affected lenses with medications that may reverse or slow lens opacity. For instance, ongoing studies on N-acetylcarnosine eye drops show potential for reducing cataract progression. Additionally, sustained-release drug implants, such as those for corticosteroid delivery, promise long-term management of cataract-related inflammation. Such advancements offer new, non-invasive treatment alternatives, complementing traditional surgical methods. By providing innovative solutions that address cataract management in novel ways, these developments are broadening market opportunities and enhancing patient care options.

• Expansion of Specialized Cataract Surgery Centres

The expansion of specialized cataract surgery centres and eye care clinics in underserved regions offers substantial opportunities for market growth by enhancing the availability of high-quality cataract care. For instance, organizations such as VisionSpring have been instrumental in setting up eye care clinics in remote areas of India and Africa, addressing the critical need for accessible and specialized cataract treatments. These centres are designed to provide comprehensive and efficient cataract care, including advanced diagnostic tools and surgical techniques, which attract patients seeking targeted treatments. By increasing the presence of such facilities in regions with limited access to specialized eye care, the market can address unmet needs, improve patient outcomes, and foster growth by capturing the demand for quality cataract services.

Restraints/Challenges

Postoperative Complications

Postoperative complications are a notable challenge in cataract surgery, despite its generally high safety profile, impacting the global cataracts market. Complications such as infection, inflammation, and visual disturbances can adversely affect patient outcomes and satisfaction. For instance, endophthalmitis, a serious infection occurring inside the eye, is a rare but severe complication that can lead to vision loss if not promptly treated. Similarly, posterior capsule opacification (PCO), where the membrane behind the lens becomes cloudy, can impair vision even after successful surgery and may require additional procedures like YAG laser capsulotomy to restore clarity. Such complications poses as a significant market challenge, as they can affect patient trust in surgical procedures, increase healthcare costs, and necessitate ongoing advancements in both surgical techniques and postoperative care.

Material Limitations

The high costs associated with advanced cataract treatments, including premium intraocular lenses (IOLs) and cutting-edge surgical technologies, pose a significant barrier to market growth, particularly in low-income and emerging markets. For instance, premium IOLs, which offer enhanced visual outcomes and reduced reliance on corrective eyewear, can cost several thousand dollars per eye, making them inaccessible to many patients in developing regions. Such financial challenge limits the adoption of such advanced solutions and prevents a substantial portion of the population from benefiting from the latest innovations in cataract care. In countries with limited healthcare budgets and lower average incomes, such as those in parts of Africa and Southeast Asia, the high cost of these treatments further exacerbates disparities in access to quality eye care. As a result, the market faces constraints in these regions, where affordability remains a critical concern, impacting the overall expansion and reach of advanced cataract treatment options.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Cataracts Market Scope

The market is segmented on the basis of type, diagnosis, treatment, end-users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Nuclear Cataract
• Cortical Cataract
• Posterior Subcapsular Cataract
• Congenital Cataracts
• Others

Diagnosis

• Visual Acuity Test
• Slit-Lamp Examination
• Retinal Exam
• Others

Treatment

• Surgery

End-Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel:

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Cataracts Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, diagnosis, treatment, end-users, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the market primarily due to the concentration of major manufacturers, substantial investment in research and development, and significant healthcare expenditures. The region's advanced healthcare infrastructure and high levels of expertise among medical professionals further bolster its market dominance. Additionally, North America's robust innovation environment supports continuous advancements in product development and clinical practices.

The Asia-Pacific region has experienced notable growth in the global cataract market during the forecast period, driven by a rising prevalence of cataracts and other eye disorders. This growth is attributed to factors such as an aging population, increasing urbanization, and improved diagnostic and treatment facilities. Enhanced awareness and access to advanced ophthalmic care are further contributing to the expansion of the cataract market in this dynamic region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Cataracts Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Cataracts Market Leaders Operating in the Market Are:

• Alcon Management S. A. (Switzerland)
• AbbVie Inc. (U.S.)
• Bausch Health Companies Inc. (Canada)
• Merck & Co. Inc. (U.S.)
• Pfizer Inc. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Amorphex Therapeutics Holdings, Inc. (U.S.)
• Astellas Pharma Inc. (Japan)
• Bayer AG (Alemanha)
• Novartis AG (Suíça)
• AstraZeneca (Reino Unido)
• Amgen Inc.
• Carl Zeiss AG (Alemanha)
• HumanOptics Holding AG (Alemanha)
• STAAR SURGICAL (EUA)

Últimos desenvolvimentos no mercado da catarata

• Em fevereiro de 2024, a Johnson & Johnson MedTech, um nome líder na saúde ocular, anunciou o lançamento das suas lentes de correção da presbiopia TECNIS PureSee na região EMEA. A LIO TECNIS PureSee distingue-se pelo seu design inovador e puramente refrativo, oferecendo uma visão ininterrupta e de alta qualidade com um contraste excecional e um desempenho em condições de pouca luz. Esta lente intraocular avançada proporciona uma nitidez visual comparável a uma LIO monofocal, estabelecendo um novo padrão na correção da presbiopia.
• Em setembro de 2024, a Alcon, líder global em cuidados oftalmológicos dedicados a ajudar as pessoas a ver de forma brilhante, anunciou novas inovações durante a Reunião Anual da Sociedade Europeia de Cirurgiões de Catarata e Refrativa (ESCRS) em Barcelona. Impulsionada pelo biómetro ARGOS e pelas futuras tecnologias de diagnóstico da Alcon, a solução de planeamento digital SMARTCataract DX, recentemente disponível, foi concebida para potenciar a eficiência do fluxo de trabalho para os consultórios.

SKU-53861